Proteasomal dysfunction in sporadic Parkinson's disease.
about
Parsing Disease-relevant Protein Modifications from Epiphenomena: Perspective on the Structural Basis of SOD1-Mediated ALS.Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI.Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein.Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative diseasegp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 and 2.Consequences of impaired purine recycling in dopaminergic neurons.Protein quality control: the who's who, the where's and therapeutic escapes.PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.Classical Parkinson disease versus Parkinson complex--reflections against staging and in favour of heterogeneity.Molecular pathways and genetic aspects of Parkinson's disease: from bench to bedside.N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.A possible pathophysiological role of tyrosine hydroxylase in Parkinson's disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer.Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.The Proteasome Inhibition Model of Parkinson's Disease.Proteasome-mediated degradation of tyrosine hydroxylase triggered by its phosphorylation: a new question as to the intracellular location at which the degradation occurs.How does conserved dopamine neurotrophic factor protect against and rescue neurodegeneration of PC12 cells?Proteomics analysis of human brain tissue infected by street rabies virus.Proteasome inhibition in medaka brain induces the features of Parkinson's disease.Parkinson's disease: experimental models and reality.27-Hydroxycholesterol increases α-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons.
P2860
Q30101060-9EB618A3-B05D-44ED-9959-18784C9AFB52Q30479870-5E136A9B-2126-4CA6-844F-FBDB355D6928Q34032608-CB0E81DB-0BE4-4B3A-85EB-2C7C749CD4EBQ34091623-BBA86E61-D615-49CE-8638-7C6FDDD49D46Q35125001-5A2BA2D6-EB23-4C2F-AF28-C1E36A1A5BECQ35626973-F1DE2C55-031A-4E11-967B-F9201F61A623Q36400476-4E25516E-BFDE-43C5-B3A1-F76A0CBF8FEFQ36432134-40477130-2A0B-438F-9A2C-AC88BD4C9423Q36602023-4CE24C70-CBF6-4320-9467-0CC6C8D7AFD7Q36861710-160358ED-183C-4FD6-BBDD-74217048507DQ37021321-723C5C7A-2A1A-4529-8062-38B8B1BEDC4CQ37603362-3D73C478-6334-4450-A3FF-C2FE55523E14Q38014332-05B4E20E-98EC-41E7-823C-84CBAE924BE5Q38912869-3473A5E3-0735-41F4-8FE6-D89F564A968AQ38996038-A6AAF811-E116-43BF-8773-243E9F782076Q39014535-15270693-05EA-4F94-A993-3DA3E610E6DBQ41429895-6557AE9B-DEDE-4675-86DC-89E0C5CEA37CQ42267742-00BC151F-D8C7-426F-9D2F-199CD95CCE6DQ42962546-06904A92-5BB0-425A-96AD-D8DEAAA51AE8Q47389506-BD3DD4B3-37E8-49B7-93AF-194A8D39289AQ55236585-70899BE1-99A1-4C52-A81B-F81027A4CDF1
P2860
Proteasomal dysfunction in sporadic Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Proteasomal dysfunction in sporadic Parkinson's disease.
@ast
Proteasomal dysfunction in sporadic Parkinson's disease.
@en
Proteasomal dysfunction in sporadic Parkinson's disease.
@nl
type
label
Proteasomal dysfunction in sporadic Parkinson's disease.
@ast
Proteasomal dysfunction in sporadic Parkinson's disease.
@en
Proteasomal dysfunction in sporadic Parkinson's disease.
@nl
prefLabel
Proteasomal dysfunction in sporadic Parkinson's disease.
@ast
Proteasomal dysfunction in sporadic Parkinson's disease.
@en
Proteasomal dysfunction in sporadic Parkinson's disease.
@nl
P2093
P1433
P1476
Proteasomal dysfunction in sporadic Parkinson's disease.
@en
P2093
Alexander Kapustin
Kevin St P McNaught
Ruth JnoBaptiste
Tehone Jackson
P304
P356
10.1212/WNL.66.10_SUPPL_4.S37
P407
P433
10 Suppl 4
P577
2006-05-01T00:00:00Z